Research on Ultrasound Diagnostic Criteria for Intracranial and Extracranial Arterial Serial Stenosis
Launched by XUANWU HOSPITAL, BEIJING · Apr 20, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how ultrasound can help doctors evaluate the severity of blockages in certain brain arteries, specifically the middle cerebral artery and the V4 segment of the vertebral artery. The goal is to create clear guidelines for using ultrasound to assess these conditions, which can help doctors make better treatment decisions and identify patients at risk for strokes. The study will involve patients who are undergoing stenting procedures for severe blockages in their carotid or vertebral arteries.
To be eligible for this trial, participants need to be at least 18 years old and have been diagnosed with significant blockages in their arteries that require stenting. They will undergo several tests, including ultrasounds and imaging studies, and will be followed for one year to monitor their health and any potential stroke-related issues. Overall, this study aims to improve how we diagnose and treat patients with these serious vascular conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients diagnosed by carotid ultrasound with severe stenosis of the extracranial segment of the internal carotid artery or severe stenosis of the initial segment of the unilateral vertebral artery;
- • 2. Perform stent placement surgery within 2 weeks of ultrasound examination, and perform DSA and CTA examinations;
- • 3. Age ≥ 18 years old;
- • 4. Clinical data is complete.
- Exclusion Criteria:
- • 1. Bilateral temporal windows are not transparent to sound;
- • 2. Patients with severe stenosis of the extracranial segment of the internal carotid artery have ipsilateral MCA occlusion/ipsilateral common carotid artery severe stenosis or occlusion;
- • 3. Patients with severe stenosis of the extracranial segment of the internal carotid artery have severe stenosis of the contralateral carotid artery;
- • 4. Patients with severe stenosis or occlusion of the anterior circulation in the initial segment of unilateral vertebral artery;
- • 5. Severe stenosis or occlusion of bilateral subclavian arteries;
- • 6. Vasospasm caused by subarachnoid hemorrhage, etc;
- • 7. Related MCA or vertebral artery thrombolysis or endovascular treatment;
- • 8. Arrhythmias such as atrial fibrillation or heart failure that affect velocity measurement;
- • 9. CT, MRI, DSA examination contraindications or refusal of examination;
- • 10. Severe bleeding disorders or coagulation dysfunction;
- • 11. Merge serious diseases of other organs or tissues.
About Xuanwu Hospital, Beijing
Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Yingqi Xing
Principal Investigator
Vascular Ultrasound Diagnosis Department, Xuanwu Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported